482 related articles for article (PubMed ID: 12930147)
1. Synthesis, biological evaluation, and receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as kappa-opioid receptor agonists endowed with antinociceptive and antiamnesic activity.
Anzini M; Canullo L; Braile C; Cappelli A; Gallelli A; Vomero S; Menziani MC; De Benedetti PG; Rizzo M; Collina S; Azzolina O; Sbacchi M; Ghelardini C; Galeotti N
J Med Chem; 2003 Aug; 46(18):3853-64. PubMed ID: 12930147
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological evaluation, and quantitative receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as novel tifluadom-like ligands with high affinity and selectivity for kappa-opioid receptors.
Cappelli A; Anzini M; Vomero S; Menziani MC; De Benedetti PG; Sbacchi M; Clarke GD; Mennuni L
J Med Chem; 1996 Feb; 39(4):860-72. PubMed ID: 8632410
[TBL] [Abstract][Full Text] [Related]
3. Enantiomers of 2-[(Acylamino)ethyl]-1,4-benzodiazepines, potent ligands of kappa-opioid receptor: chiral chromatographic resolution, configurational assignment and biological activity.
Azzolina O; Collina S; Linati L; Anzini M; Cappelli A; Scheideler MA; Sbacchi M
Chirality; 2001; 13(9):606-12. PubMed ID: 11579457
[TBL] [Abstract][Full Text] [Related]
4. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F
J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176
[TBL] [Abstract][Full Text] [Related]
5. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of novel peripherally restricted kappa-opioid receptor agonists.
Kumar V; Guo D; Cassel JA; Daubert JD; Dehaven RN; Dehaven-Hudkins DL; Gauntner EK; Gottshall SL; Greiner SL; Koblish M; Little PJ; Mansson E; Maycock AL
Bioorg Med Chem Lett; 2005 Feb; 15(4):1091-5. PubMed ID: 15686919
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of the ameliorating effect on learning and memory impairment and antinociceptive effect of KT-95 in mice.
Hiramatsu M; Mizuno N; Kanematsu K
Behav Brain Res; 2006 Feb; 167(2):219-25. PubMed ID: 16223533
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, theoretical and structural analyses, and enantiopharmacology of 3-carboxy homologs of AMPA.
Brehm L; Greenwood JR; Sløk FA; Holm MM; Nielsen B; Geneser U; Stensbøl TB; Bräuner-Osborne H; Begtrup M; Egebjerg J; Krogsgaard-Larsen P
Chirality; 2004 Aug; 16(7):452-66. PubMed ID: 15236343
[TBL] [Abstract][Full Text] [Related]
9. 10-Ketomorphinan and 3-substituted-3-desoxymorphinan analogues as mixed kappa and micro opioid ligands: synthesis and biological evaluation of their binding affinity at opioid receptors.
Zhang A; Xiong W; Bidlack JM; Hilbert JE; Knapp BI; Wentland MP; Neumeyer JL
J Med Chem; 2004 Jan; 47(1):165-74. PubMed ID: 14695830
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of 14-alkoxymorphinans. 21. Novel 4-alkoxy and 14-phenylpropoxy derivatives of the mu opioid receptor antagonist cyprodime.
Spetea M; Schüllner F; Moisa RC; Berzetei-Gurske IP; Schraml B; Dörfler C; Aceto MD; Harris LS; Coop A; Schmidhammer H
J Med Chem; 2004 Jun; 47(12):3242-7. PubMed ID: 15163203
[TBL] [Abstract][Full Text] [Related]
11. Conformationally constrained kappa receptor agonists: stereoselective synthesis and pharmacological evaluation of 6,8-diazabicyclo[3.2.2]nonane derivatives.
Geiger C; Zelenka C; Lehmkuhl K; Schepmann D; Englberger W; Wünsch B
J Med Chem; 2010 May; 53(10):4212-22. PubMed ID: 20441176
[TBL] [Abstract][Full Text] [Related]
12. Effects of the substitution of Phe4 in the opioid peptide [D-Ala8]dynorphin A-(1-11)NH2.
Vig BS; Zheng MQ; Murray TF; Aldrich JV
J Med Chem; 2003 Sep; 46(19):4002-8. PubMed ID: 12954053
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of 14-alkoxymorphinans. 18. N-substituted 14-phenylpropyloxymorphinan-6-ones with unanticipated agonist properties: extending the scope of common structure-activity relationships.
Greiner E; Spetea M; Krassnig R; Schüllner F; Aceto M; Harris LS; Traynor JR; Woods JH; Coop A; Schmidhammer H
J Med Chem; 2003 Apr; 46(9):1758-63. PubMed ID: 12699394
[TBL] [Abstract][Full Text] [Related]
14. New benzomorphan derivatives of MPCB as MOP and KOP receptor ligands.
Pasquinucci L; Iadanza M; Marrazzo A; Prezzavento O; Ronsisvalle S; Scoto GM; Parenti C; De Luca L; Ronsisvalle G
Pharmazie; 2007 Nov; 62(11):813-24. PubMed ID: 18065096
[TBL] [Abstract][Full Text] [Related]
15. Enantiospecificity of kappa receptors: comparison of racemic compounds and active enantiomers in two novel series of kappa agonist analgesics.
Colle R; Clarke GD; Dondio G; Giardina G; Petrone G; Sbacchi M; Vecchietti V
Chirality; 1992; 4(1):8-15. PubMed ID: 1322687
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and pharmacological evaluation of novel octahydro-1H-pyrido[1,2-a]pyrazine as mu-opioid receptor antagonists.
Le Bourdonnec B; Goodman AJ; Graczyk TM; Belanger S; Seida PR; DeHaven RN; Dolle RE
J Med Chem; 2006 Dec; 49(25):7290-306. PubMed ID: 17149859
[TBL] [Abstract][Full Text] [Related]
17. Azepinone as a conformational constraint in the design of kappa-opioid receptor agonists.
Tuthill PA; Seida PR; Barker W; Cassel JA; Belanger S; DeHaven RN; Koblish M; Gottshall SL; Little PJ; DeHaven-Hudkins DL; Dolle RE
Bioorg Med Chem Lett; 2004 Nov; 14(22):5693-7. PubMed ID: 15482950
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships of arodyn, a novel acetylated kappa opioid receptor antagonist.
Bennett MA; Murray TF; Aldrich JV
J Pept Res; 2005 Mar; 65(3):322-32. PubMed ID: 15787962
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and opioid activity of side-chain-to-side-chain cyclic dynorphin A-(1-11) amide analogues cyclized between positions 2 and 5. 1. Substitutions in position 3.
Vig BS; Murray TF; Aldrich JV
J Med Chem; 2004 Jan; 47(2):446-55. PubMed ID: 14711314
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and preliminary in vitro investigation of bivalent ligands containing homo- and heterodimeric pharmacophores at mu, delta, and kappa opioid receptors.
Peng X; Knapp BI; Bidlack JM; Neumeyer JL
J Med Chem; 2006 Jan; 49(1):256-62. PubMed ID: 16392810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
